Home > Publications database > Nano-structuring in Solid Oxide Fuel Cells > print

001     55582
005     20240708132834.0
024 7 _ |2 pmid
|a pmid:8615350
024 7 _ |2 DOI
|a 10.1007/s11244-006-0114-6
024 7 _ |2 WOS
|a WOS:000242689200013
024 7 _ |a altmetric:21816597
|2 altmetric
037 _ _ |a PreJuSER-55582
041 _ _ |a eng
082 _ _ |a 540
084 _ _ |2 WoS
|a Chemistry, Applied
084 _ _ |2 WoS
|a Chemistry, Physical
100 1 _ |a Serra, J.M.
|b 0
|u FZJ
|0 P:(DE-Juel1)VDB61599
245 _ _ |a Nano-structuring in Solid Oxide Fuel Cells
260 _ _ |a Bussum
|b Baltzer
|c 2006
300 _ _ |a
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |a Topics in Catalysis
|x 1022-5528
|0 16521
|y 1
|v 40
500 _ _ |a Record converted from VDB: 12.11.2012
520 _ _ |a Healthy preterm infants fed formula with long-chain n-3 fatty acids (n-3 LCFAs) from marine oil have better early visual acuity but lower plasma phosphatidylcholine (PC) arachidonic acid (AA) and growth than infants fed formula containing linolenic acid (LLA) as the sole n-3 fatty acid. This randomized, double-blind trial was designed to study the effects of a different source of n-3 LCFAs and a shorter feeding interval on visual acuity (by Teller Acuity Card) and growth of preterm infants (n = 59; 747-1275 g birth wt), some of whom required long periods of supplemental oxygen and developed bronchopulmonary dysplasia (BPD). Infants were studied at 0, 2, 4, 6, 9, and 12 mo past term. Plasma PC AA, and normalized weight, length, and head circumference were not influenced by BPD or n-3 LCFAs except that n-3 LCFA-supplemented infants weighed less at 6 (P<0.05) and 9 (P<0.01) mo and had smaller head circumferences at 9 mo (P<0.05). Compared with control infants, however, those fed n-3 LCFAs had lower weight-for-length at 2, 6, 9, and 12 mo (P<0.0003, P<0.0114, P<0.0008, and P<0.006, respectively). n-3 LCFAs improved early (2-mo) but not later acuity among infants without BPD (P<0.02). Regardless of diet, infants with BPD had poorer grating acuity at 2 (P<0.0002) and 4 (P<0.04) mo but not thereafter.
536 _ _ |a Rationelle Energieumwandlung
|c P12
|2 G:(DE-HGF)
|0 G:(DE-Juel1)FUEK402
|x 0
536 _ _ |a SOFC - Solid Oxide Fuel Cell (SOFC-20140602)
|0 G:(DE-Juel1)SOFC-20140602
|c SOFC-20140602
|x 1
|f SOFC
588 _ _ |a Dataset connected to Web of Science, Pubmed
650 _ 2 |2 MeSH
|a Arachidonic Acid: blood
650 _ 2 |2 MeSH
|a Arachidonic Acid: metabolism
650 _ 2 |2 MeSH
|a Body Height: drug effects
650 _ 2 |2 MeSH
|a Body Height: physiology
650 _ 2 |2 MeSH
|a Body Weight: drug effects
650 _ 2 |2 MeSH
|a Body Weight: physiology
650 _ 2 |2 MeSH
|a Bronchopulmonary Dysplasia: blood
650 _ 2 |2 MeSH
|a Bronchopulmonary Dysplasia: epidemiology
650 _ 2 |2 MeSH
|a Bronchopulmonary Dysplasia: physiopathology
650 _ 2 |2 MeSH
|a Docosahexaenoic Acids: blood
650 _ 2 |2 MeSH
|a Docosahexaenoic Acids: pharmacology
650 _ 2 |2 MeSH
|a Double-Blind Method
650 _ 2 |2 MeSH
|a Energy Intake: physiology
650 _ 2 |2 MeSH
|a Fatty Acids, Omega-3: administration & dosage
650 _ 2 |2 MeSH
|a Fatty Acids, Omega-3: pharmacology
650 _ 2 |2 MeSH
|a Female
650 _ 2 |2 MeSH
|a Food, Fortified
650 _ 2 |2 MeSH
|a Humans
650 _ 2 |2 MeSH
|a Incidence
650 _ 2 |2 MeSH
|a Infant, Newborn
650 _ 2 |2 MeSH
|a Infant, Premature: blood
650 _ 2 |2 MeSH
|a Infant, Premature: growth & development
650 _ 2 |2 MeSH
|a Infant, Premature: physiology
650 _ 2 |2 MeSH
|a Male
650 _ 2 |2 MeSH
|a Phosphatidylcholines: blood
650 _ 2 |2 MeSH
|a Phosphatidylcholines: metabolism
650 _ 2 |2 MeSH
|a Phosphatidylethanolamines: blood
650 _ 2 |2 MeSH
|a Phosphatidylethanolamines: metabolism
650 _ 2 |2 MeSH
|a Regression Analysis
650 _ 2 |2 MeSH
|a Visual Acuity: drug effects
650 _ 2 |2 MeSH
|a Visual Acuity: physiology
650 _ 2 |2 MeSH
|a alpha-Linolenic Acid: blood
650 _ 2 |2 MeSH
|a alpha-Linolenic Acid: pharmacology
650 _ 7 |0 0
|2 NLM Chemicals
|a Fatty Acids, Omega-3
650 _ 7 |0 0
|2 NLM Chemicals
|a Phosphatidylcholines
650 _ 7 |0 0
|2 NLM Chemicals
|a Phosphatidylethanolamines
650 _ 7 |0 25167-62-8
|2 NLM Chemicals
|a Docosahexaenoic Acids
650 _ 7 |0 463-40-1
|2 NLM Chemicals
|a alpha-Linolenic Acid
650 _ 7 |0 506-32-1
|2 NLM Chemicals
|a Arachidonic Acid
650 _ 7 |a J
|2 WoSType
653 2 0 |2 Author
|a SOFC
653 2 0 |2 Author
|a nanostructuring
653 2 0 |2 Author
|a electrocatalyst
653 2 0 |2 Author
|a cathode
653 2 0 |2 Author
|a LSFC
700 1 _ |a Uhlenbruck, S.
|b 1
|u FZJ
|0 P:(DE-Juel1)129580
700 1 _ |a Meulenberg, W. A.
|b 2
|u FZJ
|0 P:(DE-Juel1)129637
700 1 _ |a Buchkremer, H. P.
|b 3
|u FZJ
|0 P:(DE-Juel1)129594
700 1 _ |a Stöver, D.
|b 4
|u FZJ
|0 P:(DE-Juel1)129666
773 _ _ |a 10.1007/s11244-006-0114-6
|g Vol. 40
|q 40
|0 PERI:(DE-600)1500978-6
|t Topics in catalysis
|v 40
|y 2006
|x 1022-5528
856 7 _ |u http://dx.doi.org/10.1007/s11244-006-0114-6
909 C O |o oai:juser.fz-juelich.de:55582
|p VDB
913 1 _ |k P12
|v Rationelle Energieumwandlung
|l Rationelle Energieumwandlung
|b Energie
|0 G:(DE-Juel1)FUEK402
|x 0
914 1 _ |y 2006
915 _ _ |0 StatID:(DE-HGF)0010
|a JCR/ISI refereed
920 1 _ |d 31.12.2006
|g IWV
|k IWV-1
|l Werkstoffsynthese und Herstellungsverfahren
|0 I:(DE-Juel1)VDB5
|x 0
920 1 _ |0 I:(DE-82)080011_20140620
|k JARA-ENERGY
|l Jülich-Aachen Research Alliance - Energy
|g JARA
|x 1
970 _ _ |a VDB:(DE-Juel1)86642
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)IEK-1-20101013
980 _ _ |a I:(DE-82)080011_20140620
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IMD-2-20101013
981 _ _ |a I:(DE-Juel1)IEK-1-20101013
981 _ _ |a I:(DE-Juel1)VDB1047

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21